Matthias De Wachter

8PUBLICATIONS
127CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsGene expression (incl. microarray and other genome-wide approaches)Epigenetics (incl. genome methylation and epigenomics)NeurogeneticsInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 01, 2026
CMIP as a novel candidate gene for neurodevelopmental and neuropsychiatric disorders.

|Jan 28, 2026
Predictive value of seizure onset for gross motor dysfunction in individuals with pathogenic GABRB2 and GABRB3 variants.

Sebastian Ortiz, Leonardo Affronte, Chiara Bagliani

|May 24, 2025
Precision medicine in epilepsy: Clinicians' perspectives from an international qualitative study.

Matthias De Wachter, Anne Juul, Annelies Colliers

|May 23, 2025
Biallelic loss-of-function variants in ZNF142 are associated with a robust DNA methylation signature affecting a limited number of genomic loci.

Mathis Hildonen, Andrea Ciolfi, Marco Ferilli

|Feb 18, 2025
Amitriptyline use in individuals with KCNQ2/3 gain-of-function variants: A retrospective cohort study.

Matthias De Wachter, Charissa Millevert, Joost Nicolai

|Jan 29, 2025
Fibroblast transcriptomics uncovers pathogenic genomic variants in individuals with exome-negative childhood onset epilepsy.

Noor Smal, Charissa Millevert, Matthias De Wachter

Pageof 2

Frequent Collaborators

5 joint publications

Rikke Steensbjerre Møller

4 joint publications

Sarah Weckhuysen

2 joint publications

Kristof Van Schil

2 joint publications

Marco Tartaglia